Cargando…
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
BACKGROUND: High background parenchymal uptake (BPU) on molecular breast imaging (MBI) has been identified as a breast cancer risk factor. We explored the feasibility of offering a short-term intervention of low-dose oral tamoxifen to women with high BPU and examined whether this intervention would...
Autores principales: | Hruska, Carrie B., Hunt, Katie N., Conners, Amy Lynn, Geske, Jennifer R., Brandt, Kathleen R., Degnim, Amy C., Vachon, Celine M., O’Connor, Michael K., Rhodes, Deborah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408779/ https://www.ncbi.nlm.nih.gov/pubmed/30850011 http://dx.doi.org/10.1186/s13058-019-1120-5 |
Ejemplares similares
-
Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2016) -
Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018) -
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
por: O’Connor, Michael K., et al.
Publicado: (2017) -
Half-time Tc-99m sestamibi imaging with a direct conversion molecular breast imaging system
por: Hruska, Carrie B, et al.
Publicado: (2014) -
Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)